In the MS group, IL-6 levels were significantly higher than those of the healthy group during the HEP (54.47 ± 24.75 pg/mL vs. 34.49 ± 14.38 pg/mL, p = 0.001). The gene discussed is IL6; the disease is myeloid sarcoma.